ALLIANCE A031203

Primary Category:

Treatment Protocols

Disease Category:

Genitourinary, Renal, Renal Metastatic

Status:

Closed

Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma

 

Effective Monday, April 6th, 2015 at 4:30 PMĀ (ET), Alliance A031203 permanently closed to new patient accrual.

NCT#01835158

Leave a Reply